Netherlands· NL-4c7ef8b27111
Voncento 250 IU / 600 IU, Poeder en oplosmiddel voor oplossing voor injectie of infusie
A von willebrand-faktor und faktor viii in kombination product containing factor viii, humaan + von willebrand factor, humaan, registered in Netherlands by CSL Behring GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Von willebrand-faktor und faktor viii in kombination is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD06 (von willebrand-faktor und faktor viii in kombination), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Von willebrand-faktor und faktor viii in kombination · ATC B02BD06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FACTOR VIII, HUMAAN + VON WILLEBRAND FACTOR, HUMAAN
- Manufacturer
- CSL Behring GmbH
- Country
- Netherlands (NL)
- ATC code
- B02BD06
- ATC class
- von Willebrand-Faktor und Faktor VIII in Kombination
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/13/857
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02BD06
Von willebrand-faktor und faktor viii in kombination, as other registers publish it.
- PolandFANHDIInstituto Grifols S.A.
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- PolandFANHDIInstituto Grifols S.A.
- PolandFANHDIInstituto Grifols S.A.
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- FinlandHaemateCSL Behring GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b351b396-e9ed-4935-a5bb-25e2fcc4dfa6 GET /v1/drugs/b351b396-e9ed-4935-a5bb-25e2fcc4dfa6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/voncento-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Von Willebrand Factor And Coagulation Factor VIII In Combination",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp111027",
"excipients": [
"CALCIUMCHLORIDE 2-WATER (E 509)",
"HUMAAN ALBUMINE",
"NATRIUMCHLORIDE",
"SACCHAROSE",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"TROMETAMOL",
"WATER VOOR INJECTIE"
],
"substances": [
"FACTOR VIII, HUMAAN",
"VON WILLEBRAND FACTOR, HUMAAN"
],
"leaflet_url": null,
"authorised_at": "2013/08/12",
"procedure_number": "EMEA/H/C/002493",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/13/857",
"additional_monitoring": "Y"
}See everything about von willebrand-faktor und faktor viii in kombination.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.